United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u) - bisoprolol fumarate 5 mg - bisoprolol fumarate tablets are indicated in the management of hypertension. it may be used alone or in combination with other antihypertensive agents. bisoprolol fumarate tablets are contraindicated in patients with cardiogenic shock, overt cardiac failure, second or third degree av block and marked sinus bradycardia.

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u) - bisoprolol fumarate 5 mg - bisoprolol fumarate is indicated in the management of hypertension. it may be used alone or in combination with other antihypertensive agents. bisoprolol fumarate is contraindicated in patients with cardiogenic shock, overt cardiac failure, second or third degree av block, and marked sinus bradycardia.

United States - English - NLM (National Library of Medicine)

american health packaging - bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u) - bisoprolol fumarate 5 mg - bisoprolol fumarate tablets usp are indicated in the management of hypertension. it may be used alone or in combination with other antihypertensive agents. bisoprolol fumarate is contraindicated in patients with cardiogenic shock, overt cardiac failure, second or third degree av block, and marked sinus bradycardia.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - bisoprolol fumarate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - bisoprolol fumarate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - bisoprolol fumarate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - bisoprolol fumarate, quantity: 10 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; pregelatinised maize starch; croscarmellose sodium; iron oxide yellow; iron oxide red; macrogol 4000; titanium dioxide; hypromellose; lactose monohydrate - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - bisoprolol fumarate, quantity: 5 mg - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; croscarmellose sodium; iron oxide yellow; calcium hydrogen phosphate; colloidal anhydrous silica; pregelatinised maize starch; hypromellose; lactose monohydrate; macrogol 4000; titanium dioxide - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - bisoprolol fumarate, quantity: 2.5 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; pregelatinised maize starch; microcrystalline cellulose; calcium hydrogen phosphate; colloidal anhydrous silica; magnesium stearate; hypromellose; titanium dioxide; macrogol 4000; lactose monohydrate - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - bisoprolol fumarate, quantity: 2.5 mg - tablet, film coated - excipient ingredients: maize starch; colloidal anhydrous silica; microcrystalline cellulose; crospovidone; magnesium stearate; titanium dioxide; hypromellose; macrogol 400 - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides